@article{18c351237097453ebb1124f53069ecef,
title = "High-dose chemotherapy (CTM) for breast cancer.",
author = "LE Damon and JL Wolf and HS Rugo and E Gold and AR Zander and M Cassidy and G Cecchi and N Cohen and D Irwin and M Tracy and CA Ries and CA Linker",
note = "We designed and implemented a new mitoxantrone-based high-dose chemotherapy regimen to minimize pulmonary injury (seen in carmustine-based regimens) in patients with breast cancer. One hundred and ninety-one breast cancer patients (99 stage II/IIIA; 27 stage IIIB; 65 stage IV responsive to conventional-dose chemotherapy) were treated with high-dose chemotherapy (CTM) delivered over 4 days (cyclophosphamide (6 g/m2), thiotepa (600 mg/m2), and mitoxantrone (24-60 mg/m2)) followed by autologous hematopoietic stem cell rescue.",
year = "2000",
month = aug,
day = "1",
doi = "10.1038/SJ.BMT.1702481",
language = "American English",
volume = "26",
journal = "Bone Marrow Transplantation",
number = "3",
}